Home > News
16
2020-6
The application prospect of nosiheptide
The reason why nosiheptide has not developed in China is the low yield. After continuous research by Shanghai Medical University, its production has been greatly improved....
查看详情
Nosiheptide is the advantage of animal-specific antibiotics
1. Significantly promote the growth of livestock and poultry and improve feed utilization...
Indications for nocytide
This product is not only used to promote animal growth, improve feed compensation, but also can be used for antibacterial. It is highly effective against Staphylococcus aureus...
China’s 3D bioprinting vascular animals have been successfully tested in vivo
The survival rate of experimental animals was 100%. The researchers used the adipose-derived mesenchymal stem cells derived from rhesus monkeys to prepare 3D bioprint inks...
Medical technology company: Innovation is the lifeline of enterprise development
In the past few decades, the medical technology industry has been at the forefront of technological innovation, but at present, the entire medical industry is undergoing earth-shaking changes...
Pharmacological action of nocytide
Naxipeptide is a special antibiotic for sulfur polypeptide animals, which has an antibacterial effect by inhibiting the synthesis of bacterial proteins, ...
New three board biomedicine fine molecular industry four potential stocks
The share of the global biopharmaceutical market continued to increase: global biopharmaceuticals accounted for 13.7% of total drug sales from 9.9% in 2007 to 13.7% in 2013. According to EvaluatePharma, ...
The biomedical industry has huge space
Nanfang Daily News (Reporter / Niu Siyuan Tang Zikai Wang Shizhen) The 7th China Medical Industry Summit Forum co-sponsored by Guangdong Medical Valley Joint Sharing Investment, China Venture Industry Research Institute, ...
Biomedical Industry: Exploring the Path from Big Powers to Powerful Countries
New scientific and technological revolutions and industrial changes in various countries are forming major opportunities for convergence and will have far-reaching impact on the world. Seizing the opportunity, innovating and developing,...
China’s rise as a biotechnology pharmaceutical powerhouse
According to the US “Wall Street Journal” reported on April 11, China is emerging as a major producer of biotech drugs, which has attracted the attention of some of the world’s largest pharmaceutical companies....
Avilamycin Structure and Properties
The molecular formula of avilamycin is C16H88Cl2O32, the molecular weight is 1403, and the avilamycin has 14 structures from A to N. Among the 14 structures, the main function is avilamycin A, followed by Verapmycin B...
Nosiheptide Physicochemical Properties
Melting point (°C): 310～320 Toxicity LD50 (mg/kg): low toxicity. The oral LD50 of the mice and rats was greater than 10g/kg, no teratogenic and no mutagenic effect....
Basic knowledge of avilamycin
Avilamycin, also known as oxytetracycline, aramectin, avidin, and fasin, is a novel digestive enhancer and metabolic regulator that is produced by fermentation of green streptomycin-producing bacteria. ...
COPYRIGHT 2020 Shanghai Moxi Biological Technology Co.,LTD
中文
Home > News